Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
Holding TSE:BHC?
Track your performance easily
BHC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$5.45 - C$15.43
Previous CloseN/A
Volume45.48K
Average Volume (3M)239.02K
Market Cap
$4.05B
Enterprise ValueC$33.37B
Total Cash (Recent Filing)$542.00M
Total Debt (Recent Filing)$29.84B
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Feb 19, 2025EPS Estimate
1.59Last Dividend Ex-Date
Nov 10, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding367,803,400
10 Day Avg. Volume178,589
30 Day Avg. Volume239,019
Standard Deviation0.16
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.30
Price to Cash Flow (P/CF)1.70
P/FCF Ratio0.40
Enterprise Value/Market Cap8.24
Enterprise Value/Revenue3.49
Enterprise Value/Gross Profit5.38
Enterprise Value/Ebitda13.38
Forecast
1Y Price Target
C$11.88Price Target Upside10.42% Upside
Rating ConsensusHold
Number of Analyst Covering5
Bausch Health Companies News
PremiumCompany Announcements
Bausch Health’s XIFAXAN Selected for Medicare Price Negotiation
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBHC total revenue was significantly above estimates, showcasing strong performance.
Market DemandBausch & Lomb sales exceeded projections, indicating robust demand in this segment.
Strategic InitiativesThe eventual separation of BLCO would unlock value for BHC shares.
Bears Say
Debt And SolvencyWith ~$9.4B in debt coming due in the 2027/2028 timeframe, solvency remains a major concern.
EarningsEarnings per share missed expectations, highlighting a potential area of concern.
Management And StrategyCompany split process remains opaque, with management providing no new updates on timeline or path.
---
Options Prices
Currently, No data available
---
Ownership Overview
18.82% Insiders
4.02% Mutual Funds
0.07% Other Institutional Investors
72.65% Public Companies and Individual Investors
BHC FAQ
What was Bausch Health Companies’s price range in the past 12 months?
Bausch Health Companies lowest stock price was C$5.45 and its highest was C$15.43 in the past 12 months.
What is Bausch Health Companies’s market cap?
Bausch Health Companies’s market cap is $4.05B.
When is Bausch Health Companies’s upcoming earnings report date?
Bausch Health Companies’s upcoming earnings report date is Feb 19, 2025 which is in 31 days.
How were Bausch Health Companies’s earnings last quarter?
Bausch Health Companies released its earnings results on Oct 30, 2024. The company reported C$1.592 earnings per share for the quarter, beating the consensus estimate of C$1.417 by C$0.175.
Is Bausch Health Companies overvalued?
According to Wall Street analysts Bausch Health Companies’s price is currently Undervalued.
Does Bausch Health Companies pay dividends?
Bausch Health Companies pays a Quarterly dividend of C$1.434 which represents an annual dividend yield of N/A. See more information on Bausch Health Companies dividends here
What is Bausch Health Companies’s EPS estimate?
Bausch Health Companies’s EPS estimate is 1.59.
How many shares outstanding does Bausch Health Companies have?
Bausch Health Companies has 367,803,400 shares outstanding.
What happened to Bausch Health Companies’s price movement after its last earnings report?
Bausch Health Companies reported an EPS of C$1.592 in its last earnings report, beating expectations of C$1.417. Following the earnings report the stock price went up 12.665%.
Which hedge fund is a major shareholder of Bausch Health Companies?
Currently, no hedge funds are holding shares in TSE:BHC
---
Bausch Health Companies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$11.88 (10.42% Upside)
C$11.88 (10.42% Upside)
Blogger Sentiment
Bullish
TSE:BHC Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.94%
Trailing 12-Months
Company Description
Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.
---
BHC Company Deck
---
BHC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter for Bausch Health with significant revenue and EBITDA growth, leading to an increase in full-year guidance. The company showcased robust performance in international and Solta segments, along with continued growth opportunities for XIFAXAN. However, challenges remain due to ongoing litigation and increased operating expenses.Read More>---
BHC Revenue Breakdown
47.34% Bausch + Lomb
25.69% Salix
12.23% International
10.77% Diversified Products
3.96% Solta Medical
---
BHC Stock 12 Month Forecast
Average Price Target
C$11.88
▲(10.42% Upside)
Technical Analysis
Bausch Health Companies
―
Teva Pharmaceutical
―
Perrigo Company
―
Dr Reddy's Laboratories
―
Amphastar Pharmaceuticals
―
GlaxoSmithKline
―
Novartis
―
Best Analysts Covering BHC
1 Year
1 Year Success Rate
9/25 ratings generated profit
1 Year Average Return
-15.06%
reiterated a sell rating 3 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 36.00% of your transactions generating a profit, with an average return of -15.06% per trade.
---